Clinical Immunology

Article	Citations
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy	191
COVID-19: A review of therapeutic strategies and vaccine candidates	175
Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in aut	164
The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives	148
Interrelations between COVID-19 and other disorders	119
Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis	115
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine	109
Influenza infection, SARS, MERS and COVID-19: Cytokine storm – The common denominator and the lessons to be learned	106
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19	101
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study	85
SARS-CoV-2 infections in children and young people	85
Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients	82
Micronutrients as immunomodulatory tools for COVID-19 management	80
Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer	73
Galectin-3 regulates microglial activation and promotes inflammation through TLR4/MyD88/NF-kB in experimental autoimmune uveitis	61
Laboratory biomarkers associated with COVID-19 severity and management	59
Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine	59
Covid-19 vaccine and autoimmunity: Awakening the sleeping dragon	47
Genetic justification of severe COVID-19 using a rigorous algorithm	47
Macrophages in tumor: An inflammatory perspective	46
Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19	43
Major reduction of NKT cells in patients with severe COVID-19 pneumonia	43
Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death	42
Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application	41
The microbiota-mediated dietary and nutritional interventions for COVID-19	35

Interferon gamma, TGF-β1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients	34
Gut dysbiosis and multiple sclerosis	33
On the genetics and immunopathogenesis of COVID-19	32
The resurgence of a neglected orthopoxvirus: Immunologic and clinical aspects of monkeypox virus infections over the past six decades	31
Kidney tubular epithelial cell ferroptosis links glomerular injury to tubulointerstitial pathology in lupus nephritis	31
Systemic lupus erythematosus as a genetic disease	31
Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products	31
Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19	30
Lupus gut microbiota transplants cause autoimmunity and inflammation	30
Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection	30
Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus	29
ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease	29
COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review	28
Adult-onset Still's disease following mRNA COVID-19 vaccination	28
Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections	27
From discovery to approval: A brief history of the compstatin family of complement C3 inhibitors	27
Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation	27
PD-1 signaling pathway in sepsis: Does it have a future?	26
An enlightening role for cytokine storm in coronavirus infection	26
Transcriptional changes in peanut-specific CD4+ T cells over the course of oral immunotherapy	26
Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults	26
Biological effect of PM10 on airway epithelium-focus on obstructive lung diseases	26
T cell dysregulation in SLE	25
Behçet's disease with a somatic UBA1 variant:Expanding spectrum of autoinflammatory phenotypes of VEXAS syndrome	25
The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection	25
Coronavirus-induced autoimmunity	24
Treg-dependent immunosuppression triggers effector T cell dysfunction via the STING/ILC2 axis	24
Infection-induced myeloperoxidase specific antineutrophil cytoplasmic antibody (MPO-ANCA) associated vasculitis: A systematic review	24
DNA methylation signatures of autoimmune diseases in human B lymphocytes	24
SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination	24
Targeting immunometabolism against acute lung injury	24
Current insights and future prospects for the pathogenesis and treatment for rheumatoid arthritis	24
Long non-coding RNA Xist contribution in systemic lupus erythematosus and rheumatoid arthritis	24
Health-related quality of life in primary immunodeficiencies: Impact of delayed diagnosis and treatment burden	23
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer	23
T cell markers recount the course of immunosenescence in healthy individuals and chronic kidney disease	22
Exosome-mediated circ_0001846 participates in IL-1β-induced chondrocyte cell damage by miR-149-5p-dependent regulation of WNT5B	22
Capsaicin alleviates acetaminophen-induced acute liver injury in mice	22
Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study	22
Role of diet in regulating the gut microbiota and multiple sclerosis	22
Transcriptome of airway neutrophils reveals an interferon response in life-threatening respiratory syncytial virus infection	22
TNF-inhibitors or bisphosphonates in chronic nonbacterial osteomyelitis? - Results of an international retrospective multicenter study	22
The critical role of short-chain fatty acids in health and disease: A subtle focus on cardiovascular disease-NLRP3 inflammasome-angiogenesis axis	21
Immune checkpoint inhibition for the treatment of cancers: An update and critical review of ongoing clinical trials	21
Immunogenicity of SARS-CoV-2 vaccination in rituximab-treated patients: Effect of timing and immunologic parameters	21
Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway	21
Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients	21
Systemic lupus erythematosus – Are children miniature adults?	20
SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency	20
Immune modulating effects of receptor interacting protein 2 (RIP2) in autoinflammation and immunity	20

Dynamics of HIV reservoir decay and naïve CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment	20
Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors - A nationwide survey	20
Role of NRF2 and Sirtuin activators in COVID-19	20
How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC	20
Stem cell like memory T cells: A new paradigm in cancer immunotherapy	19
Association of KIR gene polymorphisms with COVID-19 disease	19
Prognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19 pneumonia: A case-control study	19
Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities	19
Association of cardiometabolic risk status with clinical activity and damage in systemic lupus erythematosus patients: A cross-sectional study	19
N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells	19
Matr3 reshapes m6A modification complex to alleviate macrophage inflammation during atherosclerosis	18
Early prediction of COVID-19 outcome using artificial intelligence techniques and only five laboratory indices	18
Seven novel podocyte autoantibodies were identified to diagnosis a new disease subgroup-autoimmune Podocytopathies	18
Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency	18
Classification of systemic lupus erythematosus in children and adults	18
Fungal infections in primary immunodeficiency diseases	18
The safety of long-term use of inhaled corticosteroids in patients with asthma: A systematic review and meta-analysis	18
Improvement of renal and non-renal SLE outcome measures on sirolimus therapy – A 21-year follow-up study of 73 patients	18
Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 lar	18
Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19	17
Myeloid-derived suppressor cells in COVID-19: A review	17
Fatal SARS-CoV-2 infection in a male patient with Good's syndrome	17
Protective HLA alleles against severe COVID-19: HLA-A*68 as an ancestral protection allele in Tapachula-Chiapas, Mexico	17
Updated therapies for the management of Psoriatic Arthritis	17
Interleukin 4 promotes anti-inflammatory macrophages that clear cartilage debris and inhibits osteoclast development to protect against osteoarthritis	17
Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients	17
Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure	16
Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19	16
Protracted stress-induced hypocortisolemia may account for the clinical and immune manifestations of Long COVID	16
Circ_0001103 alleviates IL-1β-induced chondrocyte cell injuries by upregulating SIRT1 via targeting miR-375	16
Effect of monoclonal antibody therapy on the endogenous SARS-CoV-2 antibody response	16
Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort	16
Long-term cognitive deficits after traumatic brain injury associated with microglia activation	16
The impact of BCG dose and revaccination on trained immunity	15
Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients	15
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year	15
Farnesol induces protection against murine CNS inflammatory demyelination and modifies gut microbiome	15
Cardiac pathology and outcomes vary between Kawasaki disease and PIMS-TS	15
COVID-19 in children and young adults with moderate/severe inborn errors of immunity in a high burden area in pre-vaccine era	15
Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response	14
BTK inhibitors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A systematic review	14
Identification of a potent regulatory T cell epitope in factor V that modulates CD4+ and CD8+ memory T cell responses	14
A simple and highly efficient method of IFI44L methylation detection for the diagnosis of systemic lupus erythematosus	14
RIP2 knockdown inhibits cartilage degradation and oxidative stress in IL-1β-treated chondrocytes via regulating TRAF3 and inhibiting p38 MAPK pathway	14
Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention	14
Immunophenotyping reveals distinct subgroups of lupus patients based on their activated T cell subsets	14
PARP14 promotes the growth and glycolysis of acute myeloid leukemia cells by regulating HIF-1α expression	14
Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitis	13
SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts	13
The impaired anti-tumoral effect of immune surveillance cells in the immune microenvironment of gastric cancer	13
Recent insights into the impact of immune dysfunction on reproduction in autoimmune thyroiditis	13
Expression, regulation and clinical significance of B7-H3 on neutrophils in human gastric cancer	13
Novel biallelic mutations in the DUOX2 gene underlying very early-onset inflammatory bowel disease: A case report	13
Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review	13
The NLRP3 inflammasome as a target for sensorineural hearing loss	13
Therapeutic agents affecting the immune system and drug-induced inflammatory bowel disease (IBD): A review on etiological and pathogenetic aspects	13
The FCGR2A rs1801274 polymorphism was associated with the risk of death among COVID-19 patients	13
Ectopic lymphoid structures in the aged lacrimal glands	13
Expression and clinical significance of VISTA, B7-H3, and PD-L1 in glioma	13
New laboratory criteria of the autoimmune inflammation in pulmonary sarcoidosis and tuberculosis	13
Molecular characterization of PANoptosis-related genes with features of immune dysregulation in systemic lupus erythematosus	13
mTOR signaling: A pivotal player in Treg cell dysfunction in systemic lupus erythematosus	13
Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents	13
RNA-seq characterization of histamine-releasing mast cells as potential therapeutic target of osteoarthritis	12
A global survey in the developmental landscape of possible vaccination strategies for COVID-19	12
Peroxiredoxin 4 regulates tumor-cell-like characteristics of fibroblast-like synoviocytes in rheumatoid arthritis through PI3k/Akt signaling pathway	12
A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma	12
Curb complement to cure COVID-19	12
Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors	12
Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry	12
Plasma exchange versus intravenous immunoglobulin in AChR subtype myasthenic crisis: A prospective cohort study	12
Platelet bound complement split product (PC4d) is a marker of platelet activation and arterial vascular events in Systemic Lupus Erythematosus	12
Positive rates of interferon-γ release assay and tuberculin skin test in detection of latent tuberculosis infection: A systematic review and meta-analysis of 200,000 head-to-head comparative tests	12
Invasive fungal disease and the immunocompromised host including allogeneic hematopoietic cell transplant recipients: Improved understanding and new strategic approach with sargramostim	12
Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update	12
NETosis promotes chronic inflammation and fibrosis in systemic lupus erythematosus and COVID-19	12
A novel application of delayed-type hipersensitivity reaction to measure cellular immune response in SARS-CoV-2 exposed individuals	12
Aberrant monocyte subsets in patients with Behçet's disease	12
Down-regulation of KLF2 in lung fibroblasts is linked with COVID-19 immunofibrosis and restored by combined inhibition of NETs, JAK-1/2 and IL-6 signaling	11
The role of B-cell ferroptosis in the pathogenesis of systemic lupus erythematosus	11

Temozolomide-based sonodynamic therapy induces immunogenic cell death in glioma	11
Unconventional T cells – New players in antifungal immunity	11
Effects of dietary restriction on gut microbiota and CNS autoimmunity	11
Undifferentiated recurrent fevers in pediatrics are clinically distinct from PFAPA syndrome but retain an IL-1 signature	11
PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS)	11
Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunity	11
Severe COVID-19 pneumonia in Good syndrome with a favorable outcome	11
What we have learned about lymphocytic variant hypereosinophilic syndrome: A systematic literature review	11
Revisiting immunological and clinical aspects of membranous nephropathy	11
Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis	11
The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway	11
Immunological features of circulating monocyte subsets in patients with squamous cell carcinoma of the head and neck	11
Global, regional, and national incidence and prevalence of systemic sclerosis	11
Inflammation driven metabolic regulation and adaptation in macrophages	11
Crosstalk between microglia and neural stem cells influences the relapse of glioblastoma in GBM immunological microenvironment	11
MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway	11
Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients	11
Anti-SARS-CoV-2 antibody detection in healthcare workers of two tertiary hospitals in Athens, Greece	11
Advances in the treatment of severe combined immunodeficiency	11
Extracellular vesicles of immune cells; immunomodulatory impacts and therapeutic potentials	10
Cancer germline antigen gene MAGEB2 promotes cell invasion and correlates with immune microenvironment and immunotherapeutic efficiency in laryngeal cancer	10
Feasibility of iNKT cell and PD-1+CD8+ T cell-based immunotherapy in patients with lung adenocarcinoma: Preliminary results of a phase I/II clinical trial	10
The pro-inflammatory effect of triglyceride on human CD4+ T cells and experimental autoimmune uveitis	10
HBV upregulated triggering receptor expressed on myeloid cells-1 (TREM-1) expression on monocytes participated in disease progression through NF-Kb pathway	10
Hyper IgE syndromes: A clinical approach	10
Endoplasmic reticulum stress exacerbates inflammation in chronic rhinosinusitis with nasal polyps via the transcription factor XBP1	10
Paediatric MAS/HLH caused by a novel monoallelic activating mutation in p110δ	10
METTL14-m6A-FOXO3a axis regulates autophagy and inflammation in ankylosing spondylitis	10
Integration of metabolomics and lipidomics reveals serum biomarkers for systemic lupus erythematosus with different organs involvement	10
T-cell senescence: A crucial player in autoimmune diseases	10
T cell receptor repertoire as a potential diagnostic marker for celiac disease	10
A novel intracellular nanobody against HPV16 E6 oncoprotein	10
Progesterone-induced blocking factor-mediated Th1/Th2 balance correlates with fetal arrest in women who underwent in vitro fertilization and embryo transfer	10
Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study	10
Autoantibody signatures discovered by HuProt protein microarray to enhance the diagnosis of lung cancer	10
Citrullination: A modification important in the pathogenesis of autoimmune diseases	9
Memory and naïve gamma delta regulatory T-cell gene expression in the first 24-weeks of peanut oral immunotherapy	9
Pyroptosis predicts immunotherapy outcomes across multiple cancer types	9
An Enhanced Expression Level of CXCR3 on Tfh-like Cells from Lupus Skin Lesions Rather Than Lupus Peripheral Blood	9
Immunomodulatory effect of vitamin D on the STATs and transcription factors of CD4+ T cell subsets in pregnant women with preeclampsia	9
The CGRP/macrophage axis signal facilitates inflammation recovery in the intestine	9
The FOXP3 full-length isoform controls the lineage-stability of CD4+FOXP3+ regulatory T cells	9
Epigenetic regulation is involved in traffic-related PM2.5 aggravating allergic airway inflammation in rats	9
Infection with SARS-CoV-2 primes immunological memory in human nasal-associated lymphoid tissue	9
Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy	9
Dickkopf-1 as a promising therapeutic target for autoimmune diseases	9
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children	9
Tissue distribution of γδ T cell subsets in oesophageal adenocarcinoma	9
Circular RNA VMA21 ameliorates IL-1β-engendered chondrocyte injury through the miR-495-3p/FBWX7 signaling axis	9
Benefits of LAMA in patients with asthma-COPD overlap: A systematic review and meta-analysis	9
The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses	9
Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19	9
A set of clinical and laboratory markers differentiates hyper-IgE syndrome from severe atopic dermatitis	9
Myxomavirus serpin alters macrophage function and prevents diffuse alveolar hemorrhage in pristane-induced lupus	9
How autoinflammation may turn into autoimmune inflammation: Insights from monogenetic and complex IL-1 mediated auto-inflammatory diseases	9
Associations of TNFA, IL17A, and RORC mRNA expression levels in peripheral blood leukocytes with obesity-related asthma in adolescents	9
Differential response induced by LPS and MPLA in immunocompetent and septic individuals	9
Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients	9
ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis	9
Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases	9
Formin protein DIAPH1 positively regulates PD-L1 expression and predicts the therapeutic response to anti-PD-1/PD-L1 immunotherapy	9
Prognostic role of NK cell percentages in bronchoalveolar lavage from patients with different fibrotic interstitial lung diseases	9
Long non-coding RNA: Multiple effects on the differentiation, maturity and cell function of dendritic cells	9
Ex vivo assays to detect complement activation in complementopathies	9
A novel mutation in EROS (CYBC1) causes chronic granulomatous disease	8
Endoplasmic reticulum stress impairs the immune regulation property of macrophages in asthmatic patients	8
Single-cell immune profiling of Meniere Disease patients	8
Long-term follow up of families with pathogenic NFKB1 variants reveals incomplete penetrance and frequent inflammatory sequelae	8
Immunomodulation of neutrophils and platelets by TNF blockage in patients with juvenile idiopathic arthritis	8
Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): New perspectives	8
Benralizumab in eosinophilic granulomatosis with polyangiitis complicated by Staphylococcus aureus sepsis	8
Treatment of antiphospholipid syndrome	8
JAK inhibition for CD3− CD4+ lymphocytic-variant hypereosinophilic syndrome	8
Protective role of the novel cytokine Metrnl/ interleukin-41 in host immunity defense during sepsis by promoting macrophage recruitment and modulating Treg/Th17 immune cell balance	8
The clinical and immunological characteristics in fatal severe fever with thrombocytopenia syndrome virus (SFTSV) infection	8
SARS-CoV-2-specific T cell responses in patients with multisystem inflammatory syndrome in children	8
Time course of peripheral immunophenotypes of multisystem inflammatory syndrome in children	8
BCL10 loss-of-function novel mutation leading to atypical severe combined immunodeficiency	8
Characterization of AR-CGD female patient with a novel homozygous deletion in CYBC1 gene presenting with unusual clinical phenotype	8
Serum amyloid A – A prime candidate for identification of neonatal sepsis	8
The correlation between proteoglycan 2 and neuropsychiatric systemic lupus erythematosus	8
Effect and mechanism of peanut skin proanthocyanidins on gliadin-induced Caco-2 celiac disease model cells	8
IL-4 receptor blockade is a global repressor of naïve B cell development and responses in a dupilumab-treated patient	8
Kelch-like protein 11 antibody-associated paraneoplastic neurological syndrome: A state-of-the-art review	7
T1D patient-derived hematopoietic stem cells are programmed to generate Tph, Tfh, and autoimmunity-associated B cell subsets in human immune system mice	7
High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19	7
AIM2 inflammasome: A potential therapeutic target in ischemic stroke	7
CHI3L1 predicted in malignant entities is associated with glioblastoma immune microenvironment	7
miR-126-3p and miR-16-5p as novel serum biomarkers for disease activity and treatment response in symptomatic dermographism	7
Altered NK-cell compartment and dysfunctional NKG2D/NKG2D-ligand axis in patients with ataxia-telangiectasia	7
Aberrant tolerogenic functions and proinflammatory skew of dendritic cells in STAT1 gain-of-function patients may contribute to autoimmunity and fungal susceptibility	7
Intravitreal dexamethasone implants facilitate the management of refractory Behçet's uveitis with vasculitis	7
Successful canakinumab treatment for activated innate response in idiopathic Castleman's disease with multiple heterozygous MEFV exon 2 variants	7
Interplay of redox imbalance with matrix gelatinases in neutrophils and their association with disease severity in rheumatoid arthritis patients	7
Earlier and more aggressive treatment with biologics may prevent relapses and further new organ involvement in Behçet's disease	7